Swank Capital and Cushing® MLP Asset Management Announce Rebalancing of the Cushing® MLP High Income Index
DALLAS, April 5, 2012 /PRNewswire/ -- Swank Capital, LLC and Cushing® MLP Asset Management, LP announced today that the 30 members of the Cushing® MLP High Income Index will be rebalanced after the market close on April 13, 2012 as part of normal index operations.

diaDexus, Inc. Highlights Findings from Two Outcomes Studies for its PLAC Lp-PLA(2) Activity Assay
SOUTH SAN FRANCISCO, Calif., March 19, 2012 /PRNewswire/ -- diaDexus, Inc. (OTC Bulletin Board: DDXS), a company focused on proprietary cardiovascular diagnostic products, today highlighted data from two recent studies evaluating the clinical utility of its PLAC® Test for Lp-PLA(2)  Activity.

diaDexus Launches PLAC® Test for Lp-PLA(2) Activity in Europe
SOUTH SAN FRANCISCO, March 5, 2012 /PRNewswire/ -- diaDexus, Inc. (OTC Bulletin Board: DDXS), a company focused on the development and commercialization of proprietary cardiovascular diagnostic products, today announced the commercial launch of its CE-marked PLAC® Test for Lp-PLA(2) Activity in Europe.

Swank Capital and Cushing® MLP Asset Management Announce Constituent Change to The Cushing® MLP High Income Index
DALLAS, Feb. 22 2012 /PRNewswire/ -- Swank Capital, LLC and Cushing® MLP Asset Management, LP announced today that Atlas Pipeline Partners LP (NYSE: APL) will replace Inergy LP (NYSE: NRGY) as a constituent to the Cushing® MLP High Income Index after the close of trading on Wednesday February 29, 2012 due to Inergy LP's announced reduction in its distribution.  The remaining constituents will be unaffected. Cushing® MLP High Income Index constituents (effective March 1, 2012): Company Name Ticker Tier Atlas Pipeline Partners LP NYSE: APL 1 Ferrellgas Partners  LP NYSE: FGP 1 Breitburn Energy Partners LP NASDAQ: BBEP 1 Natural Resource Partners LP NYSE: NRP ...